These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 33810328)
1. Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control. Speranza L; di Porzio U; Viggiano D; de Donato A; Volpicelli F Cells; 2021 Mar; 10(4):. PubMed ID: 33810328 [TBL] [Abstract][Full Text] [Related]
2. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra. Aumann TD J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607 [TBL] [Abstract][Full Text] [Related]
3. Dopamine and the regulation of cognition and attention. Nieoullon A Prog Neurobiol; 2002 May; 67(1):53-83. PubMed ID: 12126656 [TBL] [Abstract][Full Text] [Related]
4. Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors. Ledonne A; Mercuri NB Front Cell Neurosci; 2017; 11():27. PubMed ID: 28228718 [TBL] [Abstract][Full Text] [Related]
5. Synaptic dysfunction in Parkinson's disease. Picconi B; Piccoli G; Calabresi P Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072 [TBL] [Abstract][Full Text] [Related]
6. Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? Calabresi P; Ghiglieri V; Mazzocchetti P; Corbelli I; Picconi B Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009763 [TBL] [Abstract][Full Text] [Related]
7. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Goto Y; Grace AA Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857 [TBL] [Abstract][Full Text] [Related]
8. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Lovinger DM Neuropharmacology; 2010 Jun; 58(7):951-61. PubMed ID: 20096294 [TBL] [Abstract][Full Text] [Related]
9. Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. Calabresi P; Galletti F; Saggese E; Ghiglieri V; Picconi B Parkinsonism Relat Disord; 2007; 13 Suppl 3():S259-62. PubMed ID: 18267247 [TBL] [Abstract][Full Text] [Related]
10. A Novel and Selective Dopamine Transporter Inhibitor, Kouhnavardi S; Ecevitoglu A; Dragačević V; Sanna F; Arias-Sandoval E; Kalaba P; Kirchhofer M; Lubec J; Niello M; Holy M; Zehl M; Pillwein M; Wackerlig J; Murau R; Mohrmann A; Beard KR; Sitte HH; Urban E; Sagheddu C; Pistis M; Plasenzotti R; Salamone JD; Langer T; Lubec G; Monje FJ Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883437 [TBL] [Abstract][Full Text] [Related]
11. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Mehler-Wex C; Riederer P; Gerlach M Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic Modulation of Synaptic Plasticity, Its Role in Neuropsychiatric Disorders, and Its Computational Modeling. Madadi Asl M; Vahabie AH; Valizadeh A Basic Clin Neurosci; 2019; 10(1):1-12. PubMed ID: 31031889 [TBL] [Abstract][Full Text] [Related]